Londrina intensifica campanha de vacinação contra gripe com postos especiais

Londrina is opening its doors wider to flu shots this week, setting up a vaccination station on the ground floor of City Hall on Wednesday from 10 in the morning until 5 in the afternoon. The push is straightforward: get needles into the arms of children, elderly people, and pregnant women before the cold months arrive and respiratory viruses begin their seasonal surge.

The city has already tasted some success. Last Saturday, more than 500 people lined up for vaccines at three different locations—a community center in the north, a shopping mall, and a health clinic. But the numbers tell a more complicated story. Among Londrina's elderly residents, just under half have been vaccinated against influenza. For pregnant women, the rate climbs to nearly 86 percent. For children, it drops to barely 20 percent. The World Health Organization sets a target of 90 percent coverage across priority groups. Londrina is sitting at 43.81 percent overall.

The state health department in Paraná has decided this campaign will continue indefinitely. On Friday, officials determined that the focus on vulnerable populations should persist as long as needed, particularly as winter approaches and cases of severe acute respiratory syndrome tend to spike. The timing matters: respiratory viruses circulate most heavily during colder months, and for young children, the very old, and people with chronic illnesses, influenza can turn serious fast.

Vivian Feijó, Londrina's municipal health secretary, acknowledges the gap between where the city stands and where it needs to be. She notes that Londrina's vaccination rates actually exceed the national average—a small consolation. But she also points to a harder truth: two people in the city have already died from influenza in 2026. "We're living through a crisis of misinformation," she said, describing the cultural barriers to vaccination. "We want to draw attention, especially for children and elderly people. The statistics keep us alert, and we'll keep working without hesitation to improve these numbers."

The vaccine itself is straightforward biology. Every flu shot available through Brazil's public health system uses inactivated virus—dead virus, incapable of causing disease. The Brazilian Society of Immunizations issued a technical note this year addressing common concerns, and the data backs up the safety profile. The Butantan Institute, which manufactures the doses distributed through the public system in 2026, reports that the vaccine is more than 80 percent effective at preventing hospitalizations and deaths, particularly in vulnerable populations like small children and adults over 60. In these groups, and in people with existing chronic conditions, influenza can progress to severe respiratory syndrome or even trigger a heart attack—conditions that can be fatal. The vaccine also offers up to 60 percent protection against the main symptoms: fever, body aches, sore throat, and respiratory trouble.

The list of who qualifies for vaccination is long and specific: children from six months to under six years old, people 60 and older, pregnant women and those who have recently given birth, teachers, people with disabilities, those with chronic diseases, public transportation workers, truck drivers, health care workers, police and military personnel, incarcerated people and prison staff, and adolescents and young adults up to age 21 in the juvenile justice system. On ordinary days, vaccines are available at health clinics throughout the city, Monday through Friday, from 7 in the morning until 7 at night in urban areas.

What happens next depends partly on whether the special vaccination sites move the needle. Londrina's health officials are betting that removing barriers—offering shots in convenient locations at extended hours—will chip away at the gap between current coverage and the protection the city needs as winter settles in.